Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Status:
Completed

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

The purpose of the study is to investigate the safety, biodistribution, radiation dosimetry and pharmacokinetics of I-131-CLR1404.

Phase 1

Cellectar, Inc